AN ANALYSIS OF CLINICAL PHARMACIST INTERVENTIONS IN AN INTENSIVE-CARE UNIT

被引:7
|
作者
HASSAN, Y
AZIZ, NA
AWANG, J
AMINULDIN, AG
机构
[1] UNIV SAINS MALAYSIA,SCH MED SCI,DEPT PHARM,KUBANG KERIAN,MALAYSIA
[2] UNIV SAINS MALAYSIA,SCH MED SCI,DEPT ANAESTHESIOL,KUBANG KERIAN,MALAYSIA
关键词
D O I
10.1111/j.1365-2710.1992.tb01316.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In a 6-month study period, 170 pharmacist interventions in an intensive care unit (ICU) were analysed. Of the interventions, 68.8% were solicited and 31.2% were initiated by the pharmacists. The majority of the interventions were initiated by specialists (69.4%) followed by the medical officers (15.9%) and nurses (9.4%). Most of the interventions occurred during the grand rounds (75.9%), followed by ward visits (12.9%) and communication through the satellite pharmacy (10.5%). The most frequent type of intervention made was for indication or therapeutic efficacy followed by general product information, drug regimen, laboratory assessment, disease state, pharmaceutical availability and adverse drug reaction or side effect. It was also found that 83.7% of pharmacists' suggestions were accepted, 6.4% were accepted with changes, and 9.9% were not accepted. The majority of the interventions were made by direct verbal communications followed by telephone and written communications. In conclusion the study indicates that pharmacist therapeutic recommendations form an important integral element of patient care in an ICU.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 50 条
  • [21] Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit
    Márcia Malfará
    Maria Pernassi
    Davi Aragon
    Ana Carlotti
    [J]. International Journal of Clinical Pharmacy, 2018, 40 : 513 - 519
  • [22] INABILITY TO JUSTIFY A PART-TIME CLINICAL PHARMACIST IN A COMMUNITY-HOSPITAL INTENSIVE-CARE UNIT
    ROSENBAUM, CL
    FANT, WK
    MIYAGAWA, CI
    ARMITSTEAD, JA
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (10): : 2154 - 2157
  • [23] PHARMACIST INTERVENTIONS IN A POST-INTENSIVE CARE UNIT RECOVERY CLINIC
    Torbic, Heather
    Conroy, Grace
    Ward, Jessica
    Biehl, Michelle
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 421 - 421
  • [24] INTENSIVE-CARE - INTERNATIONAL STANDARDS FOR INTENSIVE-CARE UNIT SAFETY
    CRAWFORD, ME
    SORENSEN, MB
    DAHL, JB
    [J]. LANCET, 1993, 341 (8852): : 1061 - 1061
  • [25] Analysis of pharmacist's interventions in an intensive care unit by combining clinical pharmacy activity with computerized physician order entry
    Bouchand, Frederique
    Bouiri, Catherine
    Colin, Gwenhael
    Maxime, Virginie
    Pozzi, Delphine
    Annane, Djillali
    Villart, Maryvonne
    [J]. PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 290 - 291
  • [26] CLINICAL IMPLICATIONS OF MULTIDRUG RESISTANCE IN THE INTENSIVE-CARE UNIT
    SNYDMAN, DR
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, : 54 - 63
  • [27] CLINICAL USE OF THE BER IN AN INFANT INTENSIVE-CARE UNIT
    DESPLAND, PA
    GALAMBOS, R
    [J]. ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1980, 48 (01): : P17 - P17
  • [28] CLINICAL NUTRITIONAL ASSESSMENT IN INTENSIVE-CARE UNIT PATIENTS
    BISTOLARIDES, P
    FRASER, IM
    ROBBINS, SJ
    [J]. CRITICAL CARE MEDICINE, 1986, 14 (04) : 408 - 408
  • [29] CEFTAZIDIME - CLINICAL-EXPERIENCE IN AN INTENSIVE-CARE UNIT
    ZUCCOLI, P
    MERGONI, M
    MENGONI, M
    PASSARELLA, E
    [J]. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1983, 9 (10) : 731 - 734
  • [30] Identifying drug-related problems in the pediatric intensive care unit and evaluating clinical pharmacist interventions
    Can, Z. Y.
    Bayraktar, S.
    Sancar, M.
    Buyukkayhan, D.
    Apikoglu, S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1475 - 1476